by QFR Solutions | Jan 27, 2020 | News
Source: Fierce Biotech A report out this week by PwC thinks biotech could be in for a good year for deals as it sees the momentum from 2019 growing, although don’t expect many mega-deals. In the final year of the decade, a new report out called “Global Pharma...
by QFR Solutions | Nov 25, 2019 | News
Source: BioSpace Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and development-stage drugs and drug candidates, today announced it ranked number...
by QFR Solutions | Nov 5, 2019 | News
Source: FierceBiotech Stryker is moving to acquire fellow devicemaker Wright Medical in a $4 billion play to gain a stronger foothold in fast-growing orthopedic segments. The Amsterdam and Memphis, Tennessee-based Wright Medical posted $836 million in global net sales...
by QFR Solutions | Oct 10, 2019 | News
Source: FierceBiotech UCB Pharma has struck a $2.5 billion (€2.2 billion) deal to acquire Ra Pharmaceuticals. The takeover will give UCB control of a phase 3 rival to Alexion’s Soliris that some analysts have tipped to rack up blockbuster sales. Ra is focused on a...
by QFR Solutions | Aug 20, 2019 | News
Source: Cassiopea Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, announced today that it has...
